October 13, 2020
CMS halts COVID-19 testing in non-CLIA-certified labs
Editor's Note
The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification.
The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19 without CLIA certifications in place or performing COVID-19 testing outside the scope of existing CLIA certifications.
Free Daily News
- Study finds workforce readiness gap in new nurses
- Joint replacement manufacturer recalls products after FDA packaging warning
- Gene-edited pig kidney, heart pump combined in transplant surgery milestone
- Catheter sterility concerns prompt Class 1 FDA recall for surgery trays
- Large amounts of personal data possibly stolen in Change Healthcare cyberattack
- AI model helps predict patient decline, drive collaborative care
- One patient’s recovery highlights benefits of outpatient endoscopic spine surgery
- Getting ready for the OAS CAHPS Survey 2025 requirement
- Contribute to perioperative education with the 2024 OR Manager Salary/Career Survey
- Supply chain stability improves, but threats remain
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging